71 related articles for article (PubMed ID: 11576349)
1. LF15-0195 prevents the induction and inhibits the progression of rat anti-GBM disease.
Tesch GH; Hill PA; Wei M; Nikolic-Paterson DJ; Dutartre P; Atkins RC
Kidney Int; 2001 Oct; 60(4):1354-65. PubMed ID: 11576349
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis.
Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K
Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399
[TBL] [Abstract][Full Text] [Related]
4. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Fan JM; Nikolic-Paterson DJ; Yang N; Mu W; Pichler R; Johnson RJ; Atkins RC; Lan HY
Am J Pathol; 1999 Mar; 154(3):833-41. PubMed ID: 10079261
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation.
Ikezumi Y; Hurst LA; Masaki T; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2003 Jan; 63(1):83-95. PubMed ID: 12472771
[TBL] [Abstract][Full Text] [Related]
6. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Lan HY; Bacher M; Yang N; Mu W; Nikolic-Paterson DJ; Metz C; Meinhardt A; Bucala R; Atkins RC
J Exp Med; 1997 Apr; 185(8):1455-65. PubMed ID: 9126926
[TBL] [Abstract][Full Text] [Related]
7. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
[TBL] [Abstract][Full Text] [Related]
8. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
9. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis.
Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N
J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats.
Chadban SJ; Tesch GH; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 1997 Jun; 51(6):1809-17. PubMed ID: 9186870
[TBL] [Abstract][Full Text] [Related]
11. Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis.
Stambe C; Atkins RC; Hill PA; Nikolic-Paterson DJ
Kidney Int; 2003 Dec; 64(6):2121-32. PubMed ID: 14633134
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of acute xenograft rejection by short-term treatment with LF15-0195 and monoclonal antibody against CD45RB in a rat-to-mouse cardiac transplantation model.
Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
Transplantation; 2003 May; 75(9):1475-81. PubMed ID: 12792500
[TBL] [Abstract][Full Text] [Related]
13. Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation.
Isbel NM; Hill PA; Foti R; Mu W; Hurst LA; Stambe C; Lan HY; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Aug; 60(2):614-25. PubMed ID: 11473644
[TBL] [Abstract][Full Text] [Related]
14. Ribosomal protein S19 is a novel therapeutic agent in inflammatory kidney disease.
Lv J; Huang XR; Klug J; Fröhlich S; Lacher P; Xu A; Meinhardt A; Lan HY
Clin Sci (Lond); 2013 May; 124(10):627-37. PubMed ID: 23252627
[TBL] [Abstract][Full Text] [Related]
15. A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat.
Yu XQ; Nikolic-Paterson DJ; Mu W; Giachelli CM; Atkins RC; Johnson RJ; Lan HY
Proc Assoc Am Physicians; 1998; 110(1):50-64. PubMed ID: 9460083
[TBL] [Abstract][Full Text] [Related]
16. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T
Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430
[TBL] [Abstract][Full Text] [Related]
17. Low-dose local kidney irradiation inhibits progression of experimental crescentic nephritis by promoting apoptosis.
Liu D; Nazneen A; Taguchi T; Razzaque MS
Am J Nephrol; 2008; 28(4):555-68. PubMed ID: 18239382
[TBL] [Abstract][Full Text] [Related]
18. Induction of donor-specific allograft tolerance by short-term treatment with LF15-0195 after transplantation. Evidence for a direct effect on T-cell differentiation.
Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
Am J Transplant; 2002 Sep; 2(8):745-57. PubMed ID: 12243495
[TBL] [Abstract][Full Text] [Related]
19. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
[TBL] [Abstract][Full Text] [Related]
20. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
Zhao M; Ding J; Liu Y; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
